Innovent Biologics Investor Presentation March 2021

Innovent Biologics presented its investor update in March 2021, covering business updates, pipeline review, core strategy, financial review, and outlook. The company is focused on developing and commercializing high-quality biopharmaceuticals that are affordable to ordinary people.